Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation of long-term growth hormone replacement therapy in adult GH deficiency
2004-004292-11Phase 4Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Aug 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Quality of life and well-being after discontinuation of GH. Started Aug 2005; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2004-004292-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004292-11.